ResMed Inc. (RMD) To Go Ex-Dividend on February 10th

ResMed Inc. (ASX:RMD) announced a interim dividend on Monday, February 2nd, MarketIndexAU Dividends reports. Stockholders of record on Wednesday, March 18th will be given a dividend of 0.059 per share on Wednesday, March 18th. This represents a dividend yield of 16.0%. The ex-dividend date is Tuesday, February 10th.

ResMed Stock Performance

The company has a debt-to-equity ratio of 15.99, a quick ratio of 1.23 and a current ratio of 3.33. The stock has a market capitalization of $34.74 billion, a price-to-earnings ratio of 27.82, a P/E/G ratio of 2.01 and a beta of 0.69.

ResMed Company Profile

ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.